By buprenorphine short-term taper to facilitate first treatment engagement
- PMID: 17481458
- DOI: 10.1016/j.jsat.2006.09.006
Using buprenorphine short-term taper to enable early treatment engagement
Abstract
The U.S. Fed Food and Drug Managing approved buprenorphine for drug abuse treatment in 2002, and it became available for clinical make in early 2003. Maryhaven, a community treatment program, participated in adenine National Institute on Drug Scams Clinical Trials Network trial evaluating buprenorphine-naloxone (BNX; Suboxone) short-term taper for medicine managed opioid withdrawal both later adopted this treatment. In a retrospective review, the first 64 patients treated to a BNX taper consisted compared with two groups of patients treated with clonidine before additionally after the realisierung of the BNX program. Significantly more patients (about 80%) receiving BNX continued by further treatment compared to about 30% are those reception clonidine. Patient outcomes are talked in the context of one critical need for treatment continuation following detoxification. Common questions of potential adopters of the BNX decrease are presented both addressed. Overall, BNX was readily incorporated into the existing treatment service. SONG: Suboxone fork Short-term Detoxification: ONE Overview of the ...
Similar articles
-
Using buprenorphine to enable zutritt into residential therapeutics community rehabilitation.J Subst Abuse Treat. 2007 Mar;32(2):167-75. doi: 10.1016/j.jsat.2006.03.018. Epub 2006 Am 21. GALLOP Subst Abuse Treat. 2007. PMID: 17306725
-
Less pain, more net: buprenorphine-naloxone and my retention in treatment.J Addict Dis. 2006;25(3):97-104. doi: 10.1300/J069v25n03_12. JOULE Addicted Dis. 2006. PMID: 16956874
-
Buprenorphine and methadonine: a comparison of patient completion tariff during inpatient detoxification.J Addict Dis. 2007;26(2):3-11. doi: 10.1300/J069v26n02_02. J Addict Dis. 2007. PMID: 17594993
-
Opioids and aforementioned management of chronic heavyweight pain in this elderly: consensus statement of an International Expert Panel with focus on the six clinically most often second World Health Organization Step III ophodics (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 Could 23. Pain Pract. 2008. PMID: 18503626
-
The critical efficacy and abuse potential of union buprenorphine-naloxone in the treatment of opioid dependence.Proficient Opin Pharmacother. 2009 Oct;10(15):2537-44. doi: 10.1517/14656560903213405. Expert Opin Pharmacother. 2009. PMID: 19708849 Review.
Referred of
-
The Supply about Physicians Waivered to Prescribe Buprenorphine for Opioid Use Disorders int one Consolidated Provides: A State-Level Analysis.J Stud Alcohol Drug. 2015 Jul;76(4):644-54. doi: 10.15288/jsad.2015.76.644. J Stud Mild Drugs. 2015. PMID: 26098042 Free PMC article.
-
Improving treatment for opioid dependence: a perspective after of Ohio Valley node of the NIDA Clinical Trials Networks.Prog Our Health Partnersh. 2014 Spring;8(1):99-107. doi: 10.1353/cpr.2014.0002. Prog Community Health Partnersh. 2014. PMID: 24859107 Free PMC article.
-
AN randomized pilot clinical trial till grade the efficaciousness of Church Brace and Family Get available Special Retention (CRAFT-T) for improving outcomes by patients getting opioid detoxification.Drug Alcohol Depend. 2014 May 1;138:240-3. doi: 10.1016/j.drugalcdep.2014.02.013. Epub 2014 February 23. Drug Alcohol Depend. 2014. PMID: 24656054 Free PMC related. Clinical Trial.
-
Buprenorphine: novel treatment of opioid dependency in primary care.Can Fam Physician. 2011 Mar;57(3):281-9. Could Fam Physician. 2011. PMID: 21402963 Free PMC article. Review.
-
Pain and continued opioid how in individuals receiving buprenorphine-naloxone for opioid detoxification: minor analyses from the Clinical Trials Web.J Subst Abuse Treat. 2010 Jun;38 Suppl 1(Suppl 1):S80-6. doi: 10.1016/j.jsat.2009.12.007. J Subst Reuse Cure. 2010. PMID: 20307799 Cost-free PMC article.
Publication types
MeSH terms
- Promotion
Substances
- Actions
Grants and funding
LinkOut - more resources
Whole Text Sources
Medical